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On June 5, 2013, Ruslan Medzhitov received the Else Kro¨ner-Fresenius Immunology Award. This
recognition goes to an individual who has had such an influence on basic and medical immunology
that it is almost difficult to recall a time before his discoveries were made. But in reality, that time
was not long ago. To mark this celebratory event, I highlight the conceptual revolution spurred
by his work, which continues to inspire excitement today.Ruslan MedzhitovJaneway’s Legacy
Most experts agree that the modern fields
of immunology began with the awarding
of the 1908 Nobel Prize in Medicine to
Ilya (Elie) Mechnikov for his discovery of
cell-based immunity (i.e., phagocytes
and phagocytosis) and to Paul Ehrlich
for his work on soluble mediators of im-
munity (now known as antibodies). These
two discoveries founded distinct research
areas, with some scientists favoring
Mechnikov’s ideas on phagocytosis as
the principle mediator of immunity but
many more considering Ehrlich’s ideas
on antigen-antibody interactions most
important.
For the next 80 years, Ehrlich’s ideas
developed into what would now be
considered the field of adaptive immunity,
which focuses on understanding the
biology underlying the function of B and
T lymphocytes that express antigen-
specific receptors. Mechnikov’s ideas, in
contrast, developed into what would be
considered the field of innate immunity,
which seeks to understand the function
of phagocytes in capturing and killing
microbes. It was generally believed that,
during infections, innate and adaptive
immune responses acted independently,
with innate phagocytes functioning to
merely keep an infection under control
until the more sophisticated (but slower
acting) adaptive immune response
could be unleashed. Because the antigen
specificity of an immune reaction was
determined by T and B cells, adaptive
immunity became the ‘‘interesting’’ arm
of the immune system to study. In
contrast, much less attention was paid
to the earliest stages of an immune
response, wherein innate phagocyteswere thought to act nonspecifically to
capture and kill microbes that they
encountered.
Studies in immunology in the early and
mid-20th century focused heavily on
understanding how the exquisite antigen
specificity of immune responses was
achieved. These studies revealed that
the choice of which T or B cells to activate
was determined by their unique receptors
and that each of the 2 trillion lympho-
cytes in the human body could (in theory)
detect a distinct antigenic peptide.
Although the remarkable repertoire of
antigen-specific lymphocytes would
allow the immune system to detect
any peptide sequence, there was no
intrinsic means by which a T cell could
determine whether its receptor was spe-
cific for self, nonself, or microbial nonselfCellmolecules. Making this distinction was
critical for human health, as the only
adaptive immune responses that should
be generated are against microbial
antigens. How did the immune system
only permit activation of microbe-specific
lymphocytes?
What was largely ignored by the com-
munity at this time was the fact that,
in order for protein antigens to induce
robust T and B cell responses, these
antigens needed to be administered as
a mixture with bacterial products (known
as adjuvants). Why this mixture was
needed for immune responses to occur
was not considered in any biological
context until 1989, when the late Charles
Janeway Jr. proposed an unconventional
idea. In a landmark essay published
by Cold Spring Harbor Laboratory Press,
Janeway predicted that the innate im-
mune system (namely phagocytes) does
not operate independently of the adap-
tive immune system. Rather, the innate
immune system functions to instruct the
adaptive responses of T and B cells—
effectively determining which antigens
are of microbial origin. In Janeway’s
model, the function of phagocytes was
not simply to kill microbes and present
their antigens to T cells via major histo-
compatibility complex (MHC) proteins.
Rather, their function would be to deliver
signals that ensure that only microbe-
specific (not self-reactive) T cells ever
become active. Moreover, Janeway pro-
posed that these innate immune cells
could distinguish between broad classes
of microbes like bacteria and viruses,
such that the ensuing immune response
would be best suited to fight that partic-
ular type of pathogen.154, July 18, 2013 ª2013 Elsevier Inc. 261
After posing such a provocative idea,
the real question became how to prove
it. The fundamental prediction of Jane-
way’s model was that phagocytes had
the capacity to identify microbes specif-
ically and distinguish them from self-anti-
gens. If correct, then phagocytes should
express receptors that evolved to detect
microbes, and these receptors should
be able to induce signals that promote
activation of adaptive immunity. Janeway
recognized that the task of detecting
microbes is not unique to humans but is
a fundamental challenge faced by all
multicellular organisms. As such, he
speculated that all multicellular organisms
would encode receptors that detected
common features that define microbes
uniquely. These microbial signatures
were called pathogen-associated molec-
ular patterns (PAMPs), and their proposed
receptors were termed pattern recogni-
tion receptors (PRRs). Proposing what
the PAMPs were was easy. There was
already ample evidence that microbial
products such as bacterial lipopolysac-
charides (LPS) and viral infections
induced responses in phagocytes that
result in the secretion of immunostimula-
tory factors such as interleukin 1 (IL-1),
the first cytokine that was discovered in
the early 1980s by Charles Dinarello.
What was entirely unknown was the iden-
tity of the PRRs. How many were there?
Do they even exist at all? Are they really
conserved through evolution, as Janeway
proposed?
To many students in the field today, the
idea that the innate immune system
controls adaptive immunity does not
sound unconventional at all. In fact, this
idea is oft-considered obvious and
expected. Of course, most good ideas
are considered obvious in hindsight. It is
a huge testament to Janeway’s legacy
that his ideas have become so ingrained
in our understanding of immunity that
it is hard to even conceive of a time
when these ideas were not commonly
discussed. As will be described below,
there are few in the field who can take
more credit than Ruslan Medzhitov for
turning Janeway’s ideas into reality.
Toll-like Receptors in Pattern
Recognition
Ruslan Medzhitov joined this story in
1993, when as a graduate student at262 Cell 154, July 18, 2013 ª2013 Elsevier InMoscow State University, he read Jane-
way’s theory on innate immunity and
began an international correspondence
that led to a conceptual revolution. Medz-
hitov contacted Janeway, and the two
began a discussion that culminated in
the offer of a postdoctoral appointment
in Janeway’s lab at Yale University.
Once at Yale, Medzhitov embarked on a
mission to identify Janeway’s proposed
PRRs. Many possible approaches could
have been taken to identify these recep-
tors, but what bore fruit was an approach
that would typify Medzhitov’s scientific
inquiries over the next 15 years. That
approach built on his remarkable ability
to place several seemingly unrelated ob-
servations into a context that generates
a novel hypothesis. These ‘‘unrelated’’
observations included the following. (1)
As shown by Michael Levine and
colleagues, the fruit fly Drosophila
melanogaster utilizes the transcription
factor NF-kB to control immune re-
sponses to microbial infections. Because
NF-kB was already known as an immune
transcription factor in mammals, these
data supported Janeway’s contention
that an evolutionarily ancient signal trans-
duction pathway would be activated by
infections in diverse organisms. (2) The
Drosophila Toll receptor, a developmental
regulator cloned by Kathryn Anderson
and colleagues, was found to contain
a cytoplasmic signaling domain similar
to the mammalian IL-1 receptor. This
domain, now known as a Toll/IL-1 recep-
tor/resistance protein (TIR) domain, was
notable because it suggested that the
Toll and IL-1 receptors were related
evolutionarily. The IL-1 receptor was
identified by scientists at Immunex
Corporation and became interesting
because it was found to activate NF-kB-
mediated gene expression upon binding
to its ligand IL-1. Thus, the immune
pathways in flies and the IL-1 receptor
pathways in mammals both activated
NF-kB. Based on these data, Medzhitov
hypothesized that the mammalian PRR
would be a transmembrane protein that
contained a cytosolic TIR domain (like
the IL-1 receptor). Toll was not con-
sidered a candidate PRR, however,
because it was thought to only function
as a regulator of development, not immu-
nity. Using the conserved TIR domain
to screen EST databases and splenicc.cDNA libraries, Medzhitov identified a
human protein that did indeed contain a
transmembrane domain and a cytosolic
TIR. To his surprise, this protein turned
out to be a human homolog of the
Drosophila Toll protein, which today we
refer to as TLR4. Medzhitov went on to
demonstrate that the function of human
TLR4 was to induce the expression of
cytokines and costimulatory molecules
that were known to regulate T cell differ-
entiation and activation, thus providing
the first evidence for a protein that
fulfilled the criteria of a PRR. While
Medzhitov’s studies were still underway,
work published by Bruno Lemaitre and
Jules Hoffmann demonstrated that, in
addition to its developmental functions,
the Drosophila Toll protein functions to
detect microbial infections and induce
NF-kB-dependent protective responses.
Thus, although it remained unclear what
the mammalian Toll receptor detected,
it was hypothesized by Medzhitov and
Janeway in a Review published in Cell
in 1997 that it functioned downstream of
PAMPs. This prediction was then proven
in rapid fashion over the next several
years, most prolifically by the lab of
Shizuo Akira. Today we know that
Medzhitov’s human Toll protein is one of
many mammalian TLRs that function to
detect the presence of bacterial, viral, or
fungal PAMPs.
Unleashing a New Age of
Immunological Research
In 1999, Medzhitov obtained a faculty
position in the Immunobiology Depart-
ment at Yale University School of
Medicine. Over the next several years,
he undertook a diverse series of research
endeavors to comprehensively test the
predictions of Janeway’s Pattern Recog-
nition Hypothesis. Perhaps the most
important question to address was
whether TLR signaling was truly involved
in activation of adaptive immune
responses in vivo. This question was
addressed in a landmark study in which
Medzhitov and colleagues used mice
genetically deficient in the protein
MyD88. MyD88 is a TIR-domain-contain-
ing adaptor protein that controls signal
transduction pathways activated by
the IL-1 receptor and TLR families.
Medzhitov’s lab showed that TLR
signaling is essential for certain adaptive
immune responses to immunization.
These experiments provided the first
genetic evidence that PRRs are critical
for activation of adaptive immunity in
living animals, thus proving the most
critical point of Janeway’s theory—that
the innate immune system controls
the adaptive immune system. Also in
this study, Medzhitov’s group demon-
strated that TLR signaling is a potent
activator of dendritic cells, the primary
antigen-presenting cells of mammalian
immune systems. TLR-induced signals
activated dendritic cells to express cyto-
kines and costimulatory molecules that
promote T cell activation and differen-
tiation. It therefore became commonly
accepted that TLRs promote adaptive
immune responses by providing the sig-
nals needed to activate antigen-specific
T cells.
While the work described above was of
fundamental importance in establishing
the link between TLRs and adaptive
immunity, subsequent work from
Medzhitov’s lab highlighted the remark-
ably diverse means by which TLRs
accomplish this task. For example, over
the past decade, we have learned of the
importance of regulatory T cells (Tregs)
in preventing activation of autoreactive
T cells. The question of how Tregs
permitted microbe-specific T cell activa-
tion while preventing self-reactive T cell
responses was very much unclear. This
problem was solved, at least conceptu-
ally, when Medzhitov and colleagues
found that TLR-induced cytokines pro-
duced by dendritic cells render microbe-
specific T cells refractory to suppression
by Tregs. This study therefore established
that TLR-induced cytokines not only pro-
mote T cell activation directly, but also
make them refractory to the suppression
by Tregs.
It had therefore become clear that TLRs
activate cellular responses in dendritic
cells (and their highly related macrophage
cousins) in order to influence multiple
aspects of T cell differentiation. But it
was not clear what the role of TLRs was
in the function of other types of cells.
From 2003 to 2005, seminal studies
were published by Medzhitov’s group,
demonstrating the importance of TLR
signaling in B cells for the production of
T-cell-dependent antibodies, as well
as the importance of TLR signaling inintestinal epithelia for the maintenance of
intestinal homeostasis. This latter point
wasmost intriguing because it highlighted
the important role that TLRs play in the
interactions between our immune system
and the trillions of commensal bacteria
present in the intestine. These discoveries
helped to establish the idea that the
mammalian immune system uses TLRs
to both fight infections and maintain a
healthy mucosal environment through
interactions with the intestinal microbiota.
The studies described above high-
lighted the importance of understanding
the signal transduction pathways that
are activated by TLRs, and Medzhitov’s
group played a critical role in establishing
several principles that drive the field
today. For example, his group co-discov-
ered the first cytosolic signaling protein
(TIRAP, also known as Mal) that distin-
guishes the TLR pathways from the IL-1
receptor pathways. Subsequent to this
work, several other related proteins were
identified that now define the molecular
basis for the specific pathways activated
by TLRs. Medzhitov’s group also pro-
vided some of the first insights into the
cell biological aspects of TLR function,
and he identified the means by which
TLRs control the antimicrobial and
antigen-presenting activities of dendritic
cells. These early studies have expanded
dramatically, and today entire subfields
of immunology are devoted to defining
the signaling pathways that TLRs activate
to control cytokine expression, antigen
presentation, and host-microbe inter-
actions. All of these subfields operate
under the conceptual framework put
forth by Janeway, which were proven
and expanded on by Medzhitov and the
community at large.
A Vision into the Future
In recent years, as the fields of pattern
recognition matured, Medzhitov diversi-
fied his interests by asking deep unan-
swered questions associated with
immunology and inflammatory disorders.
For example, he has recognized the
important fact that, although TLRs control
innate and adaptive responses to mi-
crobes, they do not contribute to similar
responses that target multicellular para-
sites or allergens. These so-called type 2
immune activators trigger robust T- and
B-cell responses, but the molecular basisCellfor their detection is not explained by any
of the known PRR families. Medzhitov and
colleagues have pursued the idea that
parasites may be recognized indirectly,
for example, by the innate sensing of
enzymatic activities of proteins they
secrete. It is interesting to consider this
work in the context of Medzhitov’s early
work on TLRs. In some sense, by focusing
on understanding type 2 immune re-
sponses, he has reset the immunological
clock back to the early 1990s, when virtu-
ally nothing was known about innate trig-
gers of adaptive immunity to microbes. If
past performance is any predictor of
future behavior, we can expect new ideas
to emerge from Medzhitov’s lab on this
front as well.
Most recently, Medzhitov has taken
perhaps his broadest approach yet to un-
derstanding immunology in the context of
human health. Reaching back to his ability
to take (seemingly) unrelated observa-
tions and synthesize a unifying theme,
he has promoted the idea that there is
an inflammatory component to virtually
all human ailments, even those not typi-
cally associated with infection. He has
highlighted the fact that, in many in-
stances, the inflammatory responses
within a given tissue are more damaging
than the initial insult, even if this insult is
microbial replication. With this principle
in mind, it is possible to consider treat-
ments to diverse human ailments that in-
crease tolerance to inflammation-induced
tissue damage, rather than treatments
that target the initial insult (e.g., antibiotics
to treat infection). Though the hypotheses
outlined in this section have yet to be
proven at the molecular level in terms of
receptor/pathway identification, it is clear
that Ruslan Medzhitov has a vision of
immunology that extends far beyond the
details of TLR signaling.
Final Thoughts
The Else Kro¨ner-Fresenius Award sought
to identify a scientist whose achieve-
ments have had both an intellectual
and practical impact on human society.
With this in mind, it is worth noting
that examination of any immunology
textbook today highlights the critical role
of TLRs in controlling multiple aspects
of innate and adaptive immunity. These
principles were in no small part
established by the discoveries made by154, July 18, 2013 ª2013 Elsevier Inc. 263
Medzhitov and his lab. Although it
has only been about 15 years since
TLRs exploded onto the immunological
scene, numerous drug companies
now operate within the conceptual
framework of pattern recognition, and a
synthetic TLR ligand (monophosphoryl
lipid A) has been approved by the United
States government for widespread
use in vaccinations. Few scientists
have had a greater influence in shaping
immunological thinking over the last264 Cell 154, July 18, 2013 ª2013 Elsevier Inseveral years than Ruslan Medzhitov. He
has given us a wealth of ideas, some yet
to be tested. He has seeded the careers
of a remarkable number of independent
investigators and has inspired a new
generation of scientists hoping to follow
in his very large footsteps. He is a profes-
sional is every sense of the word and is
well respected by his colleagues. He is a
world-class mentor, a world-class orator,
and a good friend. Congratulations
Ruslan. We could not be happier for youc.and cannot wait to learn what you will
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